相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Designing the next-generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures
Diahann T. S. L. Jansen et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conferences
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2020)
Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-titer HBV Carrier Mice
Thomas Michler et al.
GASTROENTEROLOGY (2020)
Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength
Monique T. A. de Beijer et al.
JOURNAL OF VIROLOGY (2020)
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection
Nina Le Bert et al.
GASTROENTEROLOGY (2020)
Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes
Timothy Donnison et al.
VACCINE (2020)
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis
Carolina Boni et al.
GASTROENTEROLOGY (2019)
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
Andre Kunert et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Therapeutic strategies for hepatitis B virus infection: towards a cure
Gregory C. Fanning et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Predicting HLA class II antigen presentation through integrated deep learning
Binbin Chen et al.
NATURE BIOTECHNOLOGY (2019)
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer A Phase 2 Clinical Trial
Erminia Massarelli et al.
JAMA ONCOLOGY (2019)
Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection
Ruben C. Hoogeveen et al.
GUT (2019)
Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+T cells in chronically HBV-infected patients with low viral load
Anita Schuch et al.
GUT (2019)
Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection
Yang Cheng et al.
SCIENCE IMMUNOLOGY (2019)
HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo
Yingying Dou et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
Laura Rivino et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand
Mala K. Maini et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
Tomasz Ahrends et al.
IMMUNITY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
Paola Fisicaro et al.
NATURE MEDICINE (2017)
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
Mariette I. E. van Poelgeest et al.
CLINICAL CANCER RESEARCH (2016)
Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B
Jang-June Park et al.
GASTROENTEROLOGY (2016)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation
Rodney A. Rosalia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
Carolina Boni et al.
GASTROENTEROLOGY (2012)
Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B
B.-N. PHAM et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection
Claire Dunn et al.
GASTROENTEROLOGY (2009)
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial
Ninke Leffers et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+ and CD4+ T Cells
Hongwei Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection
Shinichi Asabe et al.
JOURNAL OF VIROLOGY (2009)
HLA class I supertypes: a revised and updated classification
John Sidney et al.
BMC IMMUNOLOGY (2008)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B
D Sprengers et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
C Boni et al.
JOURNAL OF HEPATOLOGY (2003)